Good Response to Cadonilimab (PD-1/CTLA-4 Bi-specific Antibody) Combined with Chemotherapy as First-line Treatment in Superaged Patient with HER2-Negative Advanced Gastric Cancer: A Case Report
1. Abstract Gastric cancer remains a considerable global health burden, with limited treatment options available for advanced cases, especially for the superaged patients (> 80 years as defined by the World Health Organization).